These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8387723)

  • 21. Tight binding of ramiprilat to ACE: consequences for pharmacokinetic and pharmacodynamic measurements.
    Brockmeier D
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):631-8. PubMed ID: 8963479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin does not prevent the attenuation of myocardial stunning by the ACE inhibitor ramiprilat.
    Rose J; Ehring T; Sakka SG; Skyschally A; Heusch G
    J Mol Cell Cardiol; 1996 Mar; 28(3):603-13. PubMed ID: 9011643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
    Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
    J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminopeptidase P: cation activation and inhibitor sensitivity are substrate-dependent.
    Lloyd GS; Turner AJ
    Biochem Soc Trans; 1995 Feb; 23(1):60S. PubMed ID: 7538950
    [No Abstract]   [Full Text] [Related]  

  • 25. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.
    Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V
    Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the interactions between the angiotensin converting enzyme inhibitor enalaprilat and calcium antagonists in rats.
    Marwood JF
    J Hypertens; 1996 Jan; 14(1):123-9. PubMed ID: 12013484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of .OH scavenging action by non-SH-containing angiotensin converting enzyme inhibitor imidaprilat using microdialysis.
    Obata T; Yamanaka Y
    J Physiol Paris; 1998 Feb; 92(1):1-4. PubMed ID: 9638590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tight binding influencing the future of pharmacokinetics.
    Brockmeier D
    Methods Find Exp Clin Pharmacol; 1998; 20(6):505-16. PubMed ID: 9789874
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of cilazaprilat and enalaprilat on experimental dermatitis in guinea pigs.
    Rosenqvist U; Persson K; Lindgren BR; Andersson RG
    Pharmacol Toxicol; 1991 May; 68(5):404-7. PubMed ID: 1719514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enalaprilat versus cilazaprilat: a comparison of allergic skin reactions in the guinea pig.
    Persson KM; Andersson RG
    Agents Actions; 1991 May; 33(1-2):97-9. PubMed ID: 1716846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicodynamic analysis of cough and inflammatory reactions by angiotensin-converting enzyme inhibitors in guinea pig.
    Ito K; Ito K; Sawada Y; Kamei J; Misawa M; Iga T
    J Pharmacol Exp Ther; 1995 Nov; 275(2):920-5. PubMed ID: 7473183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-affinity binding of the converting enzyme inhibitor, ramiprilat, to isolated human glomeruli.
    Becker RH; Albus U; Kress I; Linz W; Vasmant D; Delarue F; Sraer JD
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S31-4. PubMed ID: 2474098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different proinflammatory profile of three ACE inhibitors: cilazapril, enalaprilat, and ramiprilat.
    Rosenqvist U; Persson K; Andersson RG
    Am J Med; 1993 Apr; 94(4A):64S-66S. PubMed ID: 8387723
    [No Abstract]   [Full Text] [Related]  

  • 34. Kinetic properties of the angiotensin converting enzyme inhibitor ramiprilat.
    Bünning P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S31-5. PubMed ID: 2485060
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.